European Medicines Agency (EMA) official Marco Cavaleri said there was a link between AstraZeneca’s COVID-19 vaccine and rare reports of blood clots, including pulmonary embolism, deep vein thrombosis and thrombocytopenia, according to a Reuters report.
Two separate research groups in Europe had reached similar conclusions regarding the blood clots in March.
Get the full story from our sister site, Drug Discovery & Development.